Concepedia

Publication | Open Access

Genomic Variation in the <i>MAP3K5</i> Gene is Associated with β-Thalassemia Disease Severity and Hydroxyurea Treatment Efficacy

DOIFull Paper Access

28

Citations

51

References

2013

Year

Christina Tafrali, Arsinoi Paizi, Joseph Borg, Milena Radmilovic, Marina Bartsakoulia, Emily Giannopoulou, Olga Giannakopoulou, Maja Stojiljković-Petrović, Branka Zukić, Konstantinos Poulas,
Pharmacogenomics

Abstract

Our data suggest that these MAP3K5 variants are indicative of β-thalassemia disease severity and response to HU treatment.

References

YearCitations

Page 1